Related Experiment Video
Updated: Apr 28, 2026

09:51
A Microfluidic Platform for High-throughput Single-cell Isolation and Culture
Published on: June 16, 2016
10.9K
Single-cell trapping and selective treatment via co-flow within a microfluidic platform
A Benavente-Babace1, D Gallego-Pérez2, D J Hansford2
1CEIT-IK4 and Tecnun, University of Navarra, Manuel de Lardizabal 15, 20018 San Sebastián, Spain; CIC microGUNE, Goiru Kalea 9, 20500 Arrasate-Mondragon, Spain.
Biosensors & Bioelectronics
|June 8, 2014
Summary
This study presents an affordable microfluidic platform for precisely trapping and treating individual cells. This lab-on-a-chip device enables cost-effective drug testing and cell behavior analysis at the single-cell level.
Area of Science:
- Biomedical Engineering
- Cell Biology
- Microfluidics
Background:
- Lab on a chip (LOC) systems and microfluidics enable precise single-cell manipulation.
- Existing methods may lack cost-effectiveness or adaptability for specific cell studies.
Purpose of the Study:
- To design, fabricate, and characterize a versatile and inexpensive microfluidic platform for selective single-cell trapping and treatment.
- To demonstrate the platform's utility for studying drug effects and cell behavior under controlled conditions.
Main Methods:
- Development of a microfluidic platform utilizing laminar co-flow and hydrodynamic trapping.
- Fabrication and experimental characterization of the microfluidic device.
- Proof-of-concept cytotoxicity study using ethanol on isolated hepatocytes.
Main Results:
- Successful design, fabrication, and characterization of a cost-effective microfluidic platform.
- Demonstrated selective single-cell trapping and treatment capabilities using laminar co-flow.
- Validated the platform's effectiveness through a hepatocyte cytotoxicity study.
Conclusions:
- The developed microfluidic platform offers a simple, adaptable, and multipurpose solution for single-cell studies.
- This technology facilitates the investigation of novel drugs and dynamic cell behavior at the individual cell level.
- The platform has potential applications as a cell-based biosensor with single-cell resolution.

